Crispina Calsada serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Crispina Calsada has executed 2 insider transactions totaling $6.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 18, 2024 involved selling 5,468 shares valued at $6.5K.
Crispina Calsada currently holds 5,782 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Crispina Calsada has been a net seller of RGLS stock. They have purchased $0 and sold $6.5K worth of shares.
Crispina Calsada's most recent insider trade was on Jan 18, 2024, when they sold 5,468 shares at $1.19 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |